PNPLA3 I148M变种是型肝炎治愈后体重增加的主要驱动因素
V Pitova1,2, S Frankova1, M Holinka1,3
1Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Scientific reports
|July 15, 2025
概括
通过直接作用抗病毒药物治愈慢性型肝炎 (HCV) 的患者的BMI增加,特别是那些具有PNPLA3 G等位基因的患者. 这一遗传因素会影响HCV治疗后的BMI变化.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 遗传学 是一个遗传学.
- 代谢健康 代谢健康
背景情况:
- 直接作用抗病毒药物 (DAA) 有效地治愈慢性肝炎C (HCV).
- 在HCV治愈后,经常观察到体重指数 (BMI) 增加.
- PNPLA3基因I148M变体 (G等位基因) 与肝脏脂肪积累有关.
研究的目的:
- 确认与对照组相比,HCV治愈后患者的BMI增加.
- 调查BMI增加与PNPLA3 G等位基因携带之间的关联.
主要方法:
- 在DAA治疗3年后230名HCV患者的BMI变化与640名健康对照进行比较.
- 根据PNPLA3基因型 (CC与CG+GG) 分析的BMI变化.
- 利用等位基和多变量模型进行关联分析.
主要成果:
- 在HCV患者和对照人群中,整体BMI增加没有显著差异.
- 患有PNPLA3 CG+GG基因型的HCV患者的BMI增加明显高于CC基因型 (p=0.0045).
- 在HCV患者中,BMI的增加与PNPLA3 G等位基因携带显著相关.
结论:
- 在HCV治愈后的BMI增加受PNPLA3基因型的影响.
- PNPLA3 G基因基因携带是HCV治疗后BMI增加的重要预测因素.
- 遗传因素在成功治疗HCV后的代谢变化中起作用.
相关概念视频
Hepatic Drug Excretion: Influencing Factors
229
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
229
Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
Chronic Pancreatitis I: Introduction
166
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
166
Hepatic Drug Clearance: Effect of Protein Binding
288
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
288
Chronic Pancreatitis II: Collaborative Care
130
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
130
Hepatic Drug Clearance: Role of Transporters
103
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
103


